Living with Sars-Cov-2 Variants. An Update in the Pandemic Era | Book Publisher International

 SARS-CoV-2/COVID-19 is wreaking havoc on health systems and economics all over the world. In recent months, genomic analysis of pandemic SARS-CoV-2 isolates revealed viral variations that are less sensitive to neutralisation by convalescent plasma, vaccine-elicited plasma/sera, or SARS-CoV-2 monoclonal antibodies than previous SARS-CoV-2 strains. The emergence and spread of SARS-CoV-2 variants that evade vaccine immunity would be a cataclysmic development for a world expecting relief from the pandemic and a return to normalcy, as these could result in new infections in vaccinated people and those who have recovered from coronavirus disease 2019. (COVID-19). SARS-CoV-2 is an RNA virus (a family with a long history of adaptive evolution).

Autho(s) Details

Dr. L. E. Weimer
National Center for Global Health, Istituto Superiore di Sanità, Rome, Italy.

G. Cattari
Reparto COVID, Ospedale Marino-Alghero, ASSL Sassari, ATS Sardegna, Italy.

A. Binelli
National Center for Global Health, Istituto Superiore di Sanità, Rome, Italy.

E. Fanales Belasio
Department of Infectious Diseases, DMI, Istituto Superiore di Sanità, Rome, Italy.

S. Piras
Reparto COVID, Ospedale Marino-Alghero, ASSL Sassari, ATS Sardegna, Italy.

F. Sensi
Direzione ASSL Sassari, ATS Sardegna, Italy.

View Book:- https://stm.bookpi.org/LSCVUPE/issue/view/272